GEN Exclusives

More »

GEN News Highlights

More »
Jul 25, 2008

Blood Biomarkers for the Presence of Ruptured Atherosclerotic Plaques Identified

  • A research team from the University of Maastricht, The Netherlands, found biomarkers to detect the presence of ruptured atherosclerotic plaques. They observed that the blood of individuals with ruptured atherosclerotic plaques contained antibodies reactive against two peptides, E1 and E12.

    The presence of these antibodies was detected extremely early after the onset of symptoms of a heart attack, according to the investigators. They caution, though, that further studies on additional patients are needed before this work can be translated into the clinic.

    Scientists from Hasselt University in Belgium and Organon Biosciences, now a part of Schering-Plough, also contributed to this research. Their findings appear in The Journal of Clinical Investigation.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?